1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TFAP4 CTRPv2 pan-cancer AAC 0.17 4e-06
mRNA CELF4 CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA ZNF497 CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA SPTSSB CTRPv2 pan-cancer AAC -0.15 4e-06
mRNA TRA2A CTRPv2 pan-cancer AAC 0.15 4e-06
mRNA UHRF1 CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA FSD1 CTRPv2 pan-cancer AAC 0.18 4e-06
mRNA HM13 CTRPv2 pan-cancer AAC -0.16 4e-06
mRNA AS3MT CTRPv2 pan-cancer AAC 0.15 4e-06
mRNA SENP1 CTRPv2 pan-cancer AAC 0.16 4e-06
Download CSV